tetradecanoylphorbol acetate has been researched along with sr 11302 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dawson, MI; Dong, Z; Flavell, RA; Huang, C; Ma, WY; Rincon, M | 1 |
Colburn, NH; Ghosh, P; Li, JJ; Westergaard, C | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and sr 11302
Article | Year |
---|---|
Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Female; Fluocinolone Acetonide; Luciferases; Male; Mice; Mice, Transgenic; Papilloma; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; Retinoids; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcriptional Activation; Tretinoin | 1997 |
Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation, Neoplastic; Cells, Cultured; DNA; Genes, Reporter; Mice; NF-kappa B; Pyrrolidines; Retinoids; Tetradecanoylphorbol Acetate; Thiocarbamates; Time Factors; Transcription Factor AP-1; Transcriptional Activation; Transfection; Tumor Necrosis Factor-alpha | 1997 |